Medical, Pharma & Health

Medical and pharmaceutical teams operate under strict documentation requirements where accuracy is not just a quality standard — it is a patient safety obligation. Clinical protocols must be followed precisely, and any revision must be documented and communicated to all staff who follow them. Drug labeling changes require regulatory approval and exact tracking of what was added, removed, or modified. Regulatory submissions to agencies such as the FDA or EMA must accurately represent the current state of clinical evidence, and any difference between submitted versions must be explainable and auditable. LineDiff's precise word-level diff handles all of these document types — clinical SOPs, informed consent forms, package inserts, regulatory briefing documents — in both PDF and Word format, without requiring specialized document management software.

HIPAA compliance requires that protected health information be handled with appropriate technical safeguards. LineDiff's zero-knowledge client-side encryption provides this safeguard at the architectural level: document content is encrypted in the browser using the Web Crypto API (NIST P-256 + AES-GCM) before leaving the device, meaning LineDiff's server never receives unencrypted patient data or clinical information. This is not a policy commitment — it is a technical constraint built into how the system processes data. PHI protection is a design property of LineDiff's architecture, not an add-on compliance layer.

LineDiff's AI Pharma and Medical domain analysis reviews the computed diff and identifies changes of clinical significance: dosage modifications, contraindication additions, updated warning language, procedural step changes, and eligibility criteria revisions. Line-based comments allow clinical review team members to annotate specific changed sections with regulatory or clinical rationale, maintaining a documented record of why each change was reviewed and approved. Threaded comment discussions keep all clinical review communication anchored to the exact text it addresses.

Strict permission controls support medical documentation governance. A Medical Director or Regulatory Affairs Lead holds Owner access. The clinical team working on document revision receives Editor access. Regulatory affairs reviewers, quality assurance personnel, and external auditors receive Viewer access appropriate to their review role. PDF export produces a formatted, timestamped comparison report suitable for regulatory submission records, internal audit documentation, and pharmacovigilance file maintenance.